Tae Yoo

Dr. Tae Yoo


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
GHGeun Hong
Geun Hong
KLKwang-Woong Lee
Kwang-Woong Lee
Suk-Won SuhSuk-Won Suh
Suk-Won Suh
TYTae Yoo
Tae Yoo
HKHyeyoung Kim
Hyeyoung Kim
KSKyung Su Suh
Kyung Su Suh
Hong G, et al. J Korean Med Sci. 2013 Aug;28(8):1207-1212. http://dx.doi.org/10.3346/jkms.2013.28.8.1207

1 August 2022 in Asian Journal of Surgery
Verified
Journal Article
Open access
GCGiyuon Cho
Giyuon Cho
TYTae Yoo
Tae Yoo
WCWonbin Chang
Wonbin Chang
This study compared the effect of robotic cholecystectomy (RC) with a new port placement versus that of laparoscopic cholecystectomy (LC) on surgical pain and postoperative complications. We prospectively collected medical data from 100 patients who underwent cholecystectomy (RC = 50, LC = 50) from March 2017 to January 2019. In the RC group, ports were positioned in the left-lower, mid-lower, and umbilical areas. In the LC group, ports were placed in the xiphoid, right-upper, and umbilical areas. Patient characteristics were similar between the two groups. Pain levels at 2, 4, and 8 h were significantly lower in the RC group than in the LC group (p = 0.04, 0.02, and 0.02, respectively). The LC group received more analgesics after surgery (RC = 0.3 ± 0.5 vs. LC = 0.7 ± 0.9, p = 0.03). However, the total medical cost was significantly higher in the RC group (RC = 7355.2 ± 1270.9 USD vs. LC = 4814.8 ± 1572.5 USD, p < 0.01). Mean operative time, length of hospital stay, and postoperative complications were not significantly different between the two groups. Regardless of the surgical procedure, postoperative complications were similar. RC with the new port placement can be recommended for patients who are more concerned about postoperative pain, incision, and hospital stay than surgical cost.

1 January 2021 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
WCWonbin Chang
Wonbin Chang
TYTae Yoo
Tae Yoo
WCWon Tae Cho
Won Tae Cho
ACAnna Cho
Anna Cho
Chang W, et al. Ann Surg Treat Res. 2021 May;100(5):276-281. https://doi.org/10.4174/astr.2021.100.5.276

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
TYTae Yoo
Tae Yoo
KLKwang-Woong Lee
Kwang-Woong Lee
NYNam-Joon Yi
Nam-Joon Yi
YCYoung Rok Choi
Young Rok Choi
HKHyeyoung Kim
Hyeyoung Kim
KSKyung Su Suh
Kyung Su Suh
Yoo T, et al. J Korean Med Sci. 2016 Jul;31(7):1049-1054. http://dx.doi.org/10.3346/jkms.2016.31.7.1049

1 January 2019 in Videosurgery and Other Miniinvasive Techniques
Verified
Journal Article
Open access
WCWon Tae Cho
Won Tae Cho
TYTae Yoo
Tae Yoo
SKSung Min Kim
Sung Min Kim
With the increase in the frequency of robotic surgery, complications have also increased, including trocar site hernias, which rarely occur at the 8-mm port site after robotic cholecystectomy using the da Vinci Xi system. A 37-year-old woman was diagnosed with cholecystitis on abdominal...

1 January 2014 in Journal of Korean Medical Science
Verified
Journal Article
Open access
GHGeun Hong
Geun Hong
NYNam-Joon Yi
Nam-Joon Yi
Suk-Won SuhSuk-Won Suh
Suk-Won Suh
TYTae Yoo
Tae Yoo
HKHyeyoung Kim
Hyeyoung Kim
KSKyung Su Suh
Kyung Su Suh
Several studies have suggested that a positive lymphocyte cross-matching (XM) is associated with low graft survival rates and a high prevalence of acute rejection after adult living donor liver transplantations (ALDLTs) using a small-for-size graft. However, there is still no consensus on preoperative desensitization. We adopted the desensitization protocol from ABO-incompatible LDLT. We performed desensitization for the selected patients according to the degree of T lymphocyte cross-match titer, model for end-stage liver disease (MELD) score, and graft liver volume. We retrospectively evaluated 230 consecutive ALDLT recipients for 5 yr. Eleven recipients (4.8%) showed a positive XM. Among them, five patients with the high titer (> 1:16) by antihuman globulin-augmented method (T-AHG) and one with a low titer but a high MELD score of 36 were selected for desensitization: rituximab injection and plasmapheresis before the transplantation. There were no major side effects of desensitization. Four of the patients showed successful depletion of the T-AHG titer. There was no mortality and hyperacute rejection in lymphocyte XM-positive patients, showing no significant difference in survival outcome between two groups (P=1.000). In conclusion, this desensitization protocol for the selected recipients considering the degree of T lymphocyte cross-match titer, MELD score, and graft liver volume is feasible and safe.